Clinical Proteomics
News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.
Proteomics International Expects Licensing Deal, Medicare Coverage to Drive PromarkerD Sales in 2024
Premium
The company is making its first major commercial push for its diabetic kidney disease test via a US licensing deal it inked this spring with Sonic Healthcare.
Octave Bioscience Wins $10M Grant From Michael J. Fox Foundation
The firm will use the funds to develop a protein panel that can help assess disease activity and progression in individuals with Parkinson's.
Roughly a year after its launch, the company's Multiple Sclerosis Disease Activity (MSDA) test is being used by several dozen clinics around the country.
In a recent study, the 48-protein panel improved the diagnostic performance of existing Alzheimer's markers and helped predict progression of the disease.
Aspira, Oxford Ink Deal for Development of Endometriosis Test
The company said it plans to use the samples to support the launch of its EndoCheck blood test for endometriosis by the end of the year.